Aevi genomic medicine, inc. (GNMX)
Balance Sheet / Yearly
Sep'19Jun'19Mar'19Dec'18Sep'18Jun'18Mar'18Dec'17Sep'17Jun'17Mar'17Dec'16Sep'16Jun'16Mar'16Dec'15Sep'15Jun'15Mar'15Dec'14Sep'14Jun'14Mar'14Dec'13Sep'13Jun'13Mar'13Dec'12Sep'12Jun'12Mar'12Dec'11Sep'11Jun'11Dec'10Sep'10Jun'10
ASSETS
CURRENT ASSETS:
Cash and cash equivalents

2,381

3,437

6,948

12,076

19,602

19,151

26,520

33,729

14,960

21,357

29,203

39,838

47,257

53,686

43,892

53,064

17,725

22,012

25,159

33,288

14,706

16,429

19,141

22,390

26,791

28,979

32,463

6,431

8,999

9,040

2,593

4,995

7,570

10,116

2,859

4,778

1,363

Prepaid expenses and other current assets

403

572

650

170

538

855

801

893

954

1,075

982

335

589

1,095

787

747

-

-

-

315

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Accounts receivable and prepaid expenses

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

1,095

2,104

1,603

-

511

997

632

202

1,009

1,818

572

539

619

1,702

1,807

1,122

1,298

1,026

983

468

321

Total current assets

2,784

4,009

7,598

12,246

20,140

20,006

27,321

34,622

15,914

22,432

30,185

40,173

47,846

54,781

44,679

53,811

18,820

24,116

26,762

33,603

15,217

17,426

19,773

22,592

27,800

30,797

33,035

6,970

9,618

10,742

4,400

6,117

8,868

11,142

3,842

5,246

1,684

LONG-TERM ASSETS:
Lease deposits

11

11

11

11

11

11

11

11

11

11

11

11

30

34

24

23

83

87

83

83

28

31

42

42

46

43

45

62

59

57

57

52

59

49

46

40

32

Severance pay fund

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

99

97

99

110

102

99

96

93

243

229

283

279

264

267

259

346

353

318

276

247

Property and equipment, net

1

1

4

20

36

53

69

85

97

297

336

377

454

489

458

424

409

454

470

495

484

492

337

357

381

410

350

352

380

407

435

434

428

378

243

237

253

Operating lease right of use assets

-

-

11

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Other long-term assets

-

-

-

-

0

163

33

43

927

-

-

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Deferred issuance costs

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

278

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Deferred costs

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

34

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Total long-term assets

12

12

26

31

47

227

113

139

1,035

308

347

388

484

523

482

447

770

640

650

677

656

625

-

495

-

-

-

-

-

-

-

-

-

-

-

-

-

Deferred issuance expenses

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

0

0

40

-

0

42

0

-

-

672

405

0

Total long-term assets

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

478

-

520

696

274

737

338

728

324

311

405

402

364

316

279

Total assets

2,796

4,021

7,624

12,277

20,187

20,233

27,434

34,761

16,949

22,740

30,532

40,561

48,330

55,304

45,161

54,258

19,590

24,756

27,412

34,280

15,873

18,051

20,251

23,087

28,320

31,493

33,659

7,707

10,336

11,470

5,201

6,862

9,701

11,922

5,121

6,204

2,216

LIABILITIES AND STOCKHOLDERS' EQUITY
CURRENT LIABILITIES:
Trade payables

123

302

736

1,582

1,585

1,463

1,685

943

3,481

1,881

2,800

137

618

503

1,341

1,322

1,431

742

487

1,076

552

988

879

1,062

1,546

901

951

877

769

917

824

903

928

869

743

780

824

Other accounts payable and accrued expenses

4,130

3,387

3,156

2,763

4,850

3,480

3,054

3,197

3,376

3,036

2,650

5,446

4,878

3,424

2,214

2,586

8,812

1,844

993

2,562

1,971

1,380

-

1,952

-

-

-

-

-

-

-

-

-

-

-

-

-

Operating lease liability, current

-

-

11

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Advance payment

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

330

678

Other accounts payable and accrued expenses

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

1,998

-

2,042

1,425

1,718

1,473

1,395

1,249

1,146

1,156

1,413

1,272

1,235

1,474

1,198

Convertible debentures

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

5,460

5,251

0

Total current liabilities

4,253

3,689

3,903

4,345

6,435

4,943

4,739

4,140

6,857

4,917

5,450

5,583

5,496

3,927

3,555

3,908

10,243

2,586

1,480

3,638

2,523

2,368

2,877

3,014

3,588

2,326

2,669

2,350

2,164

2,166

1,970

2,059

2,341

2,141

7,438

7,835

2,700

LONG-TERM LIABILITIES:
Royalty agreement liability

2,000

-

-

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Accrued severance pay

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

166

354

347

368

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Accrued severance pay

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

415

467

-

439

-

-

-

-

-

-

-

-

-

-

-

-

-

Liability in respect of warrants

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

826

1,686

612

623

1,517

-

1,211

-

-

-

-

-

-

-

-

-

-

-

-

-

Accrued severance pay

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

459

-

873

1,446

1,429

1,492

1,585

1,387

1,422

1,328

1,252

1,146

1,087

1,043

995

Convertible debentures

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

992

Liability in respect of warrants

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

1,321

-

1,911

654

1,017

1,931

3,373

4,107

1,274

478

1,429

1,321

3,670

3,607

2,430

Total long-term liabilities

2,000

-

-

0

-

-

-

-

-

-

-

-

-

-

-

-

166

1,180

2,033

980

1,038

1,984

1,780

1,650

2,784

2,100

2,446

3,423

4,958

5,494

2,696

1,806

2,681

2,467

4,757

4,650

4,417

Total liabilities

6,253

3,689

3,903

4,345

6,435

4,943

4,739

4,140

6,857

4,917

5,450

5,583

5,496

3,927

3,555

3,908

10,409

3,766

3,513

4,618

3,561

4,352

4,657

4,664

6,372

4,426

5,115

5,773

7,122

7,660

4,666

3,865

5,022

4,608

12,195

12,485

7,117

COMMITMENTS AND CONTINGENCIES

-

-

-

-

-

-

-

-

-

-

-

0

-

-

-

0

-

-

-

0

-

-

-

0

-

-

-

0

-

-

0

0

-

-

0

-

-

STOCKHOLDERS' EQUITY:
Common stock - $0.0001 par value; 200,000,000 shares authorized; 64,766,882 shares issued and outstanding at September 30, 2019 and December 31, 2018

7

7

7

7

6

6

6

6

4

4

4

4

4

4

4

4

3

3

3

3

2

2

2

2

2

2

2

1

1

1

1

1

1

1

1

1

1

Additional paid-in capital

254,815

254,562

254,306

253,678

252,873

247,162

246,376

245,593

217,907

217,033

216,259

215,008

214,381

212,354

190,876

188,476

140,845

136,133

132,956

129,797

106,252

104,599

102,654

100,126

98,443

97,419

96,797

66,509

65,403

62,972

52,751

52,501

52,172

51,383

34,334

34,232

32,006

Accumulated deficit

-258,279

-254,237

-250,592

-245,753

-239,127

-231,878

-223,687

-214,978

-207,819

-199,214

-191,181

-180,034

-171,551

-160,981

-149,274

-138,130

-131,667

-115,146

-109,060

-100,138

-93,942

-90,902

-

-81,705

-

-

-

-

-

-

-

-

-

-

-

-

-

Deficit accumulated during the development stage

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

87,062

-

76,497

70,354

68,255

64,576

62,190

59,163

52,217

49,505

47,494

44,070

41,409

40,514

36,908

Total stockholders' equity

-3,457

332

3,721

7,932

13,752

15,290

22,695

30,621

10,092

17,823

25,082

34,978

42,834

51,377

41,606

50,350

9,181

20,990

23,899

29,662

12,312

13,699

15,594

18,423

21,948

27,067

28,544

1,934

3,214

3,810

535

2,997

4,679

7,314

-7,074

-6,281

-4,901

Total liabilities and stockholders' equity

2,796

4,021

7,624

12,277

20,187

20,233

27,434

34,761

16,949

22,740

30,532

40,561

48,330

55,304

45,161

54,258

19,590

24,756

27,412

34,280

15,873

18,051

20,251

23,087

28,320

31,493

33,659

7,707

10,336

11,470

5,201

6,862

9,701

11,922

5,121

6,204

2,216